ATE489388T1 - Immunmodulierende heterocyclische verbindungen - Google Patents

Immunmodulierende heterocyclische verbindungen

Info

Publication number
ATE489388T1
ATE489388T1 AT04719006T AT04719006T ATE489388T1 AT E489388 T1 ATE489388 T1 AT E489388T1 AT 04719006 T AT04719006 T AT 04719006T AT 04719006 T AT04719006 T AT 04719006T AT E489388 T1 ATE489388 T1 AT E489388T1
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
immunomodulating
immunomodulating heterocyclic
solvate
hydrate
Prior art date
Application number
AT04719006T
Other languages
English (en)
Inventor
Ian Mathews
Original Assignee
Medigene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0305876A external-priority patent/GB0305876D0/en
Priority claimed from GB0319429A external-priority patent/GB0319429D0/en
Application filed by Medigene Ltd filed Critical Medigene Ltd
Application granted granted Critical
Publication of ATE489388T1 publication Critical patent/ATE489388T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04719006T 2003-03-14 2004-03-10 Immunmodulierende heterocyclische verbindungen ATE489388T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0305876A GB0305876D0 (en) 2003-03-14 2003-03-14 Immuno inhibitory heterocyclic compounds
GB0319429A GB0319429D0 (en) 2003-08-19 2003-08-19 Immuno Inhibitory Heterocyclic compounds
PCT/GB2004/001008 WO2004081011A1 (en) 2003-03-14 2004-03-10 Immunomodulating heterocyclic compounds

Publications (1)

Publication Number Publication Date
ATE489388T1 true ATE489388T1 (de) 2010-12-15

Family

ID=32992598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04719006T ATE489388T1 (de) 2003-03-14 2004-03-10 Immunmodulierende heterocyclische verbindungen

Country Status (19)

Country Link
US (3) US7276505B2 (de)
EP (2) EP1603917B1 (de)
JP (1) JP4892338B2 (de)
KR (1) KR101133959B1 (de)
AT (1) ATE489388T1 (de)
BR (1) BRPI0408365B8 (de)
CA (1) CA2519063C (de)
DE (1) DE602004030225D1 (de)
DK (1) DK1603917T3 (de)
EA (2) EA009680B1 (de)
EC (1) ECSP056104A (de)
IL (1) IL170389A (de)
MX (1) MXPA05009667A (de)
NO (1) NO332136B1 (de)
NZ (1) NZ541973A (de)
PL (2) PL383655A1 (de)
PT (1) PT1603917E (de)
SI (1) SI1603917T1 (de)
WO (1) WO2004081011A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408365B8 (pt) * 2003-03-14 2021-05-25 Avidex Ltd compostos heterocíclicos de imunomodulação
GB0325644D0 (en) * 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
CN1997645B (zh) * 2004-08-09 2012-05-23 麦迪金股份公司 免疫调节作为cd80抑制剂的氧代吡唑并噌啉类
CA2618888A1 (en) * 2005-08-10 2007-02-15 Bayer Schering Pharma Aktiengesellschaft Acyltryptophanols for fertility control
GB0603522D0 (en) * 2006-02-22 2006-04-05 Avidex Ltd Kinase inhibition
EP1994022A2 (de) 2006-03-15 2008-11-26 Wyeth a Corporation of the State of Delaware N-substituierte azacyclylamine als histamin-3-antagonisten
CN101432261A (zh) 2006-05-19 2009-05-13 惠氏公司 作为组织胺-3拮抗剂的n-苯甲酰基-吡咯烷-3-基胺和n-苄基-吡咯烷-3-基胺
US20100093867A1 (en) * 2006-07-05 2010-04-15 Ryoichi Matsuda Method Of Treating Genetic Disease Caused By Nonsense Mutation
PE20081152A1 (es) 2006-10-06 2008-08-10 Wyeth Corp Azaciclilaminas n-sustituidas como antagonistas de histamina-3
CA2693138A1 (en) 2007-07-16 2009-01-22 Wyeth Llc Aminoalkylazole derivatives as histamine-3 antagonists
EP2020404A1 (de) * 2007-08-01 2009-02-04 Bayer Schering Pharma Aktiengesellschaft Cyanomethyl-substituierte N-Acyl-Tryptamine
ES2460897T3 (es) 2007-10-04 2014-05-14 F. Hoffmann-La Roche Ag Derivados de ciclopropil aril amida y usos de los mismos
GB201021104D0 (en) 2010-12-13 2011-01-26 Univ Leuven Kath Novel compounds for the treatment of neurodegenerative diseases
EP2676666A1 (de) 2012-06-20 2013-12-25 Eidgenössische Technische Hochschule Zürich (ETH) Verbindungen zur Verwendung bei der Diagnose oder Therapie anfälliger atherosklerotischer Plaques
EP2883883A1 (de) 2013-12-16 2015-06-17 Cardio3 Biosciences S.A. Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
WO2016040508A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds
JP7120549B2 (ja) * 2016-12-15 2022-08-17 小野薬品工業株式会社 Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB629412A (en) 1946-12-24 1949-09-20 Geigy Ag J R Manufacture of metallisable monoazo dyestuffs of the pyrazolone series
US3576637A (en) * 1967-04-20 1971-04-27 Konishiroku Photo Ind Lith-type of emulsion containing pyrozolone
JPS61161285A (ja) * 1984-12-28 1986-07-21 ルセル−ユクラフ ピラゾロ〔４，３−ｃ〕シンノリン−３−オンの誘導体、それらの塩類、これらの製造法、薬剤としての使用、これらを含有する組成物及び中間体生成物
US4591589A (en) * 1985-01-16 1986-05-27 Roussel Uclaf 2-aryl pyrazolo[4,3-c]cinnolin-3-ones
DE3626221A1 (de) 1986-08-02 1988-02-04 Agfa Gevaert Ag Farbfotografisches aufzeichnungsmaterial zur herstellung farbiger aufsichtsbilder
DE3789754T2 (de) 1986-11-20 1994-12-15 Mitsubishi Chem Ind Die Bildung von Lipid-peroxiden hemmende Zusammenstzung und dafür geeignete Verbindungen.
DE3903993A1 (de) * 1989-02-10 1990-08-16 Basf Ag Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus
AR006520A1 (es) * 1996-03-20 1999-09-08 Astra Pharma Prod Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion.
GB9713707D0 (en) 1997-06-27 1997-09-03 Merck Sharp & Dohme Therapeutic agents
SE0102404D0 (sv) 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
ATE527247T1 (de) 2001-07-05 2011-10-15 Takeda Pharmaceutical Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung
US7566711B2 (en) * 2001-10-12 2009-07-28 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
WO2004048378A1 (en) 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity
EP1572689B1 (de) 2002-12-16 2009-03-11 Active Biotech AB Tetrazyklische immunmodulierende verbindungen
BRPI0408365B8 (pt) * 2003-03-14 2021-05-25 Avidex Ltd compostos heterocíclicos de imunomodulação
GB0325644D0 (en) * 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
CN1997645B (zh) * 2004-08-09 2012-05-23 麦迪金股份公司 免疫调节作为cd80抑制剂的氧代吡唑并噌啉类
US20060221590A1 (en) * 2005-03-31 2006-10-05 Edoardo Campini System and method for Advanced Mezzanine Card connection
GB0603522D0 (en) 2006-02-22 2006-04-05 Avidex Ltd Kinase inhibition

Also Published As

Publication number Publication date
EP1603917B1 (de) 2010-11-24
EA200501370A1 (ru) 2006-08-25
BRPI0408365A (pt) 2006-03-21
DK1603917T3 (da) 2011-02-28
US7598247B2 (en) 2009-10-06
US20080045527A1 (en) 2008-02-21
JP4892338B2 (ja) 2012-03-07
NZ541973A (en) 2009-06-26
PT1603917E (pt) 2011-02-04
EP2284172A1 (de) 2011-02-16
CA2519063C (en) 2011-05-10
HK1090921A1 (zh) 2007-01-05
KR20050121681A (ko) 2005-12-27
PL1603917T3 (pl) 2011-12-30
PL383655A1 (pl) 2008-04-14
NO20054710L (no) 2005-12-13
US7276505B2 (en) 2007-10-02
US8309552B2 (en) 2012-11-13
EA014080B1 (ru) 2010-08-30
EP1603917A1 (de) 2005-12-14
JP2006520372A (ja) 2006-09-07
KR101133959B1 (ko) 2012-04-09
CA2519063A1 (en) 2004-09-23
US20090312334A1 (en) 2009-12-17
NO20054710D0 (no) 2005-10-13
MXPA05009667A (es) 2006-01-27
EA009680B1 (ru) 2008-02-28
BRPI0408365B1 (pt) 2018-11-21
NO332136B1 (no) 2012-07-02
AU2004220310A1 (en) 2004-09-23
ECSP056104A (es) 2006-03-01
BRPI0408365B8 (pt) 2021-05-25
WO2004081011A1 (en) 2004-09-23
US20070021428A1 (en) 2007-01-25
SI1603917T1 (sl) 2011-04-29
IL170389A (en) 2013-08-29
EA200702435A1 (ru) 2008-06-30
DE602004030225D1 (de) 2011-01-05

Similar Documents

Publication Publication Date Title
ATE489388T1 (de) Immunmodulierende heterocyclische verbindungen
GB2392154B (en) Protein Kinase Inhibitors
GB2398781B (en) Kinase inhibitors
GB0214149D0 (en) Chemical compounds
NL300927I9 (nl) Tivozanib of een zout, solvaat of hydraat ervan, in het bijzonder het hydrochloride-monohydraat
TW200732306A (en) Pyrimidine derivatives
PT1585739E (pt) Arilciclopropilacetamidas substitu?das como activadores da glucocinase
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
MXPA05013349A (es) Derivados de 2-amino-pirimidina como inhibidores de quinasa raf.
NO20061157L (no) 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
DE60319080D1 (de) Phenyloxyalkansäure-derivate als hppar aktivatore
NO20054669L (no) Substituerte kinobenzoxazinanaloger
WO2005003087A3 (en) Oxazole derivatives as antibacterial agents
MXPA05011276A (es) Derivado heterociclico de cinco miembros.
GB0215392D0 (en) Chemical compounds
DE602004031878D1 (de) Immunhemmende pyrazolon-verbindungen
EP1559716A4 (de) Pyrazolonaphthyridinderivat
MXPA06004299A (es) Derivados de arilespirofuropiridina.
TW200518748A (en) Chemical compounds
WO2004103305A3 (en) Spiropyrazole compound
DOP2002000354A (es) Compuestos farmaceuticamente activos.
MXPA05005830A (es) Metodos para preparar derivados de fenilalquino.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1603917

Country of ref document: EP